Sabra Health Care REIT director Michael Foster sells $200,376 in stock

Published 22/05/2025, 19:58
Sabra Health Care REIT director Michael Foster sells $200,376 in stock

In a recent transaction, Michael J. Foster, a director at Sabra Health Care REIT (NYSE:WELL), Inc. (NASDAQ:SBRA), sold 11,000 shares of the company’s common stock. The $4.09 billion healthcare REIT maintains a robust 6.94% dividend yield and has consistently paid dividends for 15 consecutive years, according to InvestingPro data. The shares were sold at a price of $18.216 each, amounting to a total transaction value of $200,376. Following this sale, Foster retains direct ownership of 64,725 shares. Additionally, Foster holds 42,411.745 shares indirectly through a 401(k) plan.

This transaction was filed with the Securities and Exchange Commission for the reporting period ending May 20, 2025.

In other recent news, Sabra Healthcare REIT Inc . reported its first-quarter 2025 earnings, meeting analysts’ expectations with an earnings per share (EPS) of $0.17. The company’s revenue slightly exceeded projections, coming in at $183.54 million compared to the expected $179.48 million. Sabra also reaffirmed its 2025 earnings guidance, indicating continued growth prospects. The company has been active in strategic acquisitions, with over $200 million in deals awarded, primarily in senior housing. Notably, these acquisitions are not yet included in the current guidance, as mentioned by the company’s CFO, Michael Costa. Sabra’s management highlighted a strong deal pipeline, with a focus on senior housing and skilled nursing segments. The company also reported an increase in cash rental income from its triple net portfolio, totaling $90 million for the quarter. Analyst discussions during the earnings call touched on the company’s strategic focus on acquisitions and its cautious approach to growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.